InvestorsHub Logo
Followers 74
Posts 15841
Boards Moderated 0
Alias Born 04/26/2010

Re: CaptBeer post# 368985

Monday, 02/07/2022 4:41:46 PM

Monday, February 07, 2022 4:41:46 PM

Post# of 425975
Thanks - personally, I would hammer them for not taking hospital and economic costs into account when evaluating a new drug - QALY is only a small part of the total financial equation. You have an MI and end up in the hospital for 4 days like my little brother did last summer you have a large cost for the hospital bill, his lost wages for days he missed work (you don't go right back to work just because you're released from the hospital), the loss to his employer who didn't get his work contribution, cost of an ambulance ride and the EMS's it carried (huge in the US), plus some other costs I can't remember right now. I know somebody has come up with a total economic cost of an MI, either here on this board, or maybe AMRN themselves - can't point you to it though. It really chaps my ass that they actually claimed there is no group of patients for which paying for V makes sense - that's a ridiculous conclusion, and worse, it's based on a bunch of "what if's?".

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News